首页 › 基金 › Tetragon Partners GP Ltd › GLUE
Tetragon Partners GP Ltd 对 GLUE 的持仓历史
MONTE ROSA THERAPEUTICS INC · 医疗保健
Tetragon Partners GP Ltd 在 Q3 2026 的 13F 申报中披露持有 GLUE(MONTE ROSA THERAPEUTICS INC)56,052 股,市值约 US$669K,约占其申报组合的 0.09%,在其申报持仓中市值排名第 31 位。 Tetragon Partners GP Ltd 最近 2 个申报季度中有 2 个季度披露了 GLUE 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Tetragon Partners GP Ltd 对 GLUE 的持仓演变
Tetragon Partners GP Ltd 于 Q2 2026 首次披露 GLUE 持仓:56,052 股(约 US$1.4M)。 在 2 次申报中,Tetragon Partners GP Ltd 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 56,052 股、市值约 US$669K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 56.05K | $1.36M | 新进 |
| Q3 2026 | 56.05K | $668.70K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GLUE 与 13F 数据
GLUE(MONTE ROSA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 60 只申报持有 GLUE,申报仓位最大的包括:NEA Management Company, LLC (US$186.2M), Vestal Point Capital, LP (US$111.3M), BVF INC/IL (US$108.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GLUE 的基金
- NEA Management Company, LLC 7.69M 股 · $186.15M · Q2 2026
- Vestal Point Capital, LP 4.60M 股 · $111.32M · Q2 2026
- BVF INC/IL 4.46M 股 · $107.95M · Q2 2026
- BAKER BROS. ADVISORS LP 4.35M 股 · $105.17M · Q2 2026
- MONTANOVA CAPITAL, LLC 3.55M 股 · $85.90M · Q2 2026
- BRAIDWELL LP 2.45M 股 · $59.33M · Q2 2026
- TCG Crossover Management, LLC 3.78M 股 · $45.11M · Q3 2026
- Versant Venture Management, LLC 3.18M 股 · $37.95M · Q3 2026
- Bellevue Group AG 1.19M 股 · $28.80M · Q2 2026
- MPM BioImpact LLC 1.16M 股 · $28.10M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.00M 股 · $24.20M · Q2 2026
- Aisling Capital Management LP 1.56M 股 · $18.56M · Q3 2026
更多关于 Tetragon Partners GP Ltd
常见问题
How long has Tetragon Partners GP Ltd held GLUE?
Tetragon Partners GP Ltd has disclosed GLUE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Tetragon Partners GP Ltd's current position in GLUE?
As of Q3 2026, Tetragon Partners GP Ltd holds 56.05K shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $668.70K, representing 0.09% of its reported portfolio and ranking #31.
Has Tetragon Partners GP Ltd been buying or selling GLUE?
In the latest 13F filing (Q3 2026), Tetragon Partners GP Ltd held unchanged its position in GLUE.
Which other funds hold GLUE?
Other major institutional holders of GLUE include NEA Management Company, LLC, Vestal Point Capital, LP, BVF INC/IL, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.